Literature DB >> 19593618

Synchronous bilateral breast cancer in a male patient following hormone therapy for prostate cancer.

Yuko Kijima1, Heiji Yoshinaka, Munetsugu Hirata, Yoshihisa Umekita, Sumika Matsukita, Takashi Arima, Masayuki Nakagawa, Hizuru Kumemura, Nobuo Hamada, Koichi Kaneko, Yawara Funasako, Shoji Natsugoe.   

Abstract

We report an unusual case of bilateral, synchronous breast cancer in a male patient who had a history of estrogen therapy for prostate cancer. A 64-year-old Japanese man was diagnosed with T1N0M0 prostate cancer and received a total prostatectomy. Twenty months after the resection, the patient developed multiple bone metastases, and received radiation therapy, systemic chemotherapy, and hormone therapy for 15 months. After completing this treatment, he was diagnosed with T1N0M0 primary breast cancer in his left breast and underwent a modified mastectomy. Five months after the mastectomy he received systemic chemotherapy followed by estrogen therapy because of the progression of prostate cancer. Three months after this treatment, he was diagnosed with T1N0M0 primary breast cancer in his right breast. To the best of our knowledge, this is a rare case of synchronous bilateral male breast cancer following hormone therapy for prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19593618     DOI: 10.1007/s10147-008-0824-9

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  34 in total

Review 1.  Prevention and management of hereditary breast cancer.

Authors:  Steven A Narod; Kenneth Offit
Journal:  J Clin Oncol       Date:  2005-03-10       Impact factor: 44.544

2.  Breast cancer as a second primary in patients with prostate cancer--estrogen treatment or association with family history of cancer?

Authors:  Camilla Thellenberg Karlsson; Beatrice Malmer; Fredrik Wiklund; Henrik Grönberg
Journal:  J Urol       Date:  2006-08       Impact factor: 7.450

Review 3.  Synchronous bilateral primary male breast carcinoma with hyperprolactinemia.

Authors:  P Karamanakos; V Apostolopoulos; S Fafouliotis; A Mela; Y Ziounas; D T Trafalis
Journal:  Acta Oncol       Date:  1996       Impact factor: 4.089

4.  Role of immunocytochemistry in diagnosis of prostatic neoplasia by fine needle aspiration biopsy.

Authors:  R L Katz; P Raval; T E Brooks; N G Ordóñez
Journal:  Diagn Cytopathol       Date:  1985 Jan-Mar       Impact factor: 1.582

Review 5.  Antiandrogen monotherapy: a new form of treatment for patients with prostate cancer.

Authors:  G J Kolvenbag; P Iversen; D W Newling
Journal:  Urology       Date:  2001-08       Impact factor: 2.649

6.  [A male case of primary bilateral breast cancers during estrogen therapy for prostate cancer].

Authors:  A Emoto; N Nasu; H Mimata; Y Nomura; H Mizokuchi; M Wada
Journal:  Nihon Hinyokika Gakkai Zasshi       Date:  2001-11

7.  Cancer incidence and mortality in men with Klinefelter syndrome: a cohort study.

Authors:  Anthony J Swerdlow; Minouk J Schoemaker; Craig D Higgins; Alan F Wright; Patricia A Jacobs
Journal:  J Natl Cancer Inst       Date:  2005-08-17       Impact factor: 13.506

Review 8.  Multiple primary malignant neoplasms. The Connecticut experience, 1935-1964.

Authors:  B S Schoenberg
Journal:  Recent Results Cancer Res       Date:  1977

9.  Familial male breast cancer is not linked to the BRCA1 locus on chromosome 17q.

Authors:  M R Stratton; D Ford; S Neuhasen; S Seal; R Wooster; L S Friedman; M C King; V Egilsson; P Devilee; R McManus
Journal:  Nat Genet       Date:  1994-05       Impact factor: 38.330

10.  ON BILHARZIASIS AND MALE BREAST CANCER IN EGYPT: A PRELIMINARY REPORT AND REVIEW OF THE LITERATURE.

Authors:  M M EL-GAZAYERLI; A S ABDEL-AZIZ
Journal:  Br J Cancer       Date:  1963-12       Impact factor: 7.640

View more
  1 in total

1.  Development of male breast cancer in a patient with prostate cancer during androgen deprivation therapy.

Authors:  Hiroya Mizusawa; Akira Komatsu; Yuji Mimura; Toshitaka Maejima
Journal:  IJU Case Rep       Date:  2022-01-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.